Contacts and information for SARS-CoV-2/COVID-19 researchers.
NOTE ABOUT SCHEDULE: Beyond those projects already initiated, Cornell University (Ithaca) cannot accept personnel or research activities in their BSL-3 SARS-CoV-2 facility at this time. For the next 14 days (beginning 3/17/2020), we will be ramping up our training of personnel and preparing for ongoing and future research activities.
We are available for discussions regarding future projects once all our training is completed, and in preparation for our ramped up research capabilities as they come online. Please refer to the list of expert faculty with whom you can discuss your ideas.
IMPORTANT NEED FOR CLINICAL MATERIAL: While we are not accepting new projects, we have urgent need for human clinical material from which to isolate SARS-CoV-2/COVID-19 virus for our ongoing studies. Contact Gary Whittaker if you can provide this material URGENTLY.
Research Areas and Contacts
As a first step, researchers from Cornell, Weill Cornell Medicine, or from any institution, may contact our experts in various disciplines (below) to discuss potential research collaborations. This is not a mandatory step, but is highly encouraged.
Institutional Approval for SARS-CoV-2/COVID-19 Research
As a second step, any research collaborations with Cornell (Ithaca) investigators that involves SARS-CoV-2/COVID-19 must first be deemed as “critical” through approval by the SARS-CoV-2 Essential Research Approval Committee (SERAC). The mission of SERAC is to provide a central approval process for allowing essential research activities relating to alleviating the current pandemic outbreak of the SARS-CoV-2/COVID19 virus, and to prepare the Cornell research community to become a significant component of global efforts to understand and control the spread of this virus over the long term. We are a rapid research proposal review committee.
For more details on this procedure and the application process, see the SARS-CoV-2 Research Approval Process page. Further information may be obtained from Paula Cohen, Associate Vice Provost for Life Sciences.
How can we help?
- Funding Opportunities and Agency Guidance Updated April 6
- Letter of support for your SARS-CoV-2/COVID-19 grant. Contact Carmel Lee.
NOTE ABOUT MOUSE STUDIES: We are not currently set up for mouse studies, but are in the queue to receive hACE2 mice from Jackson Laboratories. If you can provide these mice to us sooner than the end of April, please contact Gary Whittaker.